February 28, 2018 / 7:43 AM / 10 months ago

BRIEF-Xbrane Biopharma Q4 EBITDA Loss Widens To SEK 18.0 Mln

Feb 28 (Reuters) - XBRANE BIOPHARMA AB:

* Q4 EBITDA LOSS SEK 18.0‍​ MILLION VERSUS LOSS SEK 8.1 MILLION YEAR AGO

* ‍PROPOSE NO DIVIDEND FOR FISCAL YEAR 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below